Behavioural Neurology

Behavioural Neurology / 1993 / Article

Open Access

Volume 6 |Article ID 892685 |

M. Y. Neufeld, F. Mawassi, A. Levy, T. A. Treves, A. D. Korczyn, "Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping", Behavioural Neurology, vol. 6, Article ID 892685, 3 pages, 1993.

Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping

Received01 Mar 1993
Accepted16 Mar 1993


Nine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant effect of TPh on EEG spectra in patients with PDD.

Copyright © 1993 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.